Literature DB >> 17370329

Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine-tiling oligonucleotide array CGH.

Rachael Natrajan1, Richard D Williams, Anita Grigoriadis, Alan Mackay, Kerry Fenwick, Alan Ashworth, Jeffrey S Dome, Paul E Grundy, Kathy Pritchard-Jones, Chris Jones.   

Abstract

Wilms tumor karyotypes frequently exhibit recurrent, large-scale chromosomal imbalances, among the most common of which are concurrent loss of 1p and gain of 1q. We have previously identified a novel breakpoint at 1p13 by 1 Mb-spaced array CGH, and have now undertaken a fine-tiling oligonucleotide array approach to map the region accurately in four tumors exhibiting rearrangements at this locus. The use of a 10 bp-spaced platform revealed that all four tumors in fact harbored different breakpoints, which targeted intragenic sequences in PHTF1, DCLRE1B, and NRAS, and an intergenic region immediately downstream of TRIM33. All four genes and breakpoints were within the 1.78 Mb intervals identified by the genome-wide BAC arrays. The precise breakpoint interval was in each case mapped to a 200-1,200 bp region and was confirmed for one case to lie within intron 3 of DCLRE1B by quantitative PCR. Analysis of local genome architecture revealed no convincing conservation of repetitive sequences or specific translocation/recombination-associated elements within the breakpoint regions. This study highlights the power of fine-tiling oligonucleotide arrays to delineate breakpoint regions identified by genome-wide screens.

Entities:  

Mesh:

Year:  2007        PMID: 17370329     DOI: 10.1002/gcc.20446

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

Review 1.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 2.  How will telomeric complex be further contributed to our longevity? - the potential novel biomarkers of telomere complex counteracting both aging and cancer.

Authors:  Yiming Lu; Bohua Wei; Tao Zhang; Zi Chen; Jing Ye
Journal:  Protein Cell       Date:  2013-07-18       Impact factor: 14.870

3.  Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.

Authors:  Ming-Ru Chiang; Chi-Wen Kuo; Wen-Chung Wang; Tai-Cheng Hou; Chen-Yun Kuo; Meng-Yao Lu; Yen-Chein Lai
Journal:  Pathol Oncol Res       Date:  2019-01-23       Impact factor: 3.201

4.  LRIG2 mutations cause urofacial syndrome.

Authors:  Helen M Stuart; Neil A Roberts; Berk Burgu; Sarah B Daly; Jill E Urquhart; Sanjeev Bhaskar; Jonathan E Dickerson; Murat Mermerkaya; Mesrur Selcuk Silay; Malcolm A Lewis; M Beatriz Orive Olondriz; Blanca Gener; Christian Beetz; Rita E Varga; Omer Gülpınar; Evren Süer; Tarkan Soygür; Zeynep B Ozçakar; Fatoş Yalçınkaya; Aslı Kavaz; Burcu Bulum; Adnan Gücük; Wyatt W Yue; Firat Erdogan; Andrew Berry; Neil A Hanley; Edward A McKenzie; Emma N Hilton; Adrian S Woolf; William G Newman
Journal:  Am J Hum Genet       Date:  2013-01-11       Impact factor: 11.025

Review 5.  SNM1B/Apollo in the DNA damage response and telomere maintenance.

Authors:  Maren Schmiester; Ilja Demuth
Journal:  Oncotarget       Date:  2017-07-18

6.  Transformation-induced stress at telomeres is counteracted through changes in the telomeric proteome including SAMHD1.

Authors:  Jana Majerska; Marianna Feretzaki; Galina Glousker; Joachim Lingner
Journal:  Life Sci Alliance       Date:  2018-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.